Latest in Finance

Nuritas secures $42m Series C funding to revolutionise ingredient discovery and improve the lives of billions

Nuritas, a trailblazer in AI-powered peptide discovery, has successfully closed an oversubscribed $42 million Series C funding round

Find out more
You need to be a subscriber to read this article.
Click here to find out more.

Plant-based alternatives: new approaches to price parity

More and more consumers expect plant-based alternatives to deliver high-quality eating enjoyment at fair prices

 See more

dsm-firmenich awards Nutrition Research Grants totalling €250,000 to APAC-based gut health researchers

The nutrition-focused company will award up to €50,000 to each recipient to advance research on pre-, pro- and postbiotics, as well as human milk oligosaccharides (HMOs) on gut health and overall wellness

CV Sciences acquires premium cannabinoid producer and distributor, Extract Labs

Extract Labs' range of nutraceuticals suitable for both B2B and B2C customers will bolster CV Science's product range, which include plant-based ingredients and functional foods

Happy Plant Protein secures €1.8m to develop and license its plant-based protein ingredients

The manufacturing process developed by Happy Plant Protein can reduce plant-based protein production costs by up to 90%, while also creating functional food products with a 70–80% protein content

Arla Foods Ingredients one step closer to getting the Volac acquisition go-ahead

This follows the UK Competition and Market Authority's approval of Arla's acquisition of Volac's whey nutrition business

Miura Partners becomes the majority shareholder of HealthTech BioActives

The nutraceutical specialist will now be able to grow its functional health, taste modulation and animal nutrition divisions

OmniActive acquires functional ingredients specialist, ENovate Biolife

The purchase will bolster OmniActive's range of botanical nutraceuticals for active nutrition, joint health, heart health and men's wellness

ARTAH Nutrition bags £2.85m investment to grow its dietary supplement business

The company will use the investment to expand the reach of its metabolic health-boosting supplements across Europe

NutriScience Innovations acquires nutraceutical supplier, XSTO Solutions

The purchase will add six new functional ingredients to NutriScience's portfolio, allowing the company to better serve its clients in the dietary supplement industry

Latest posts in Finance

KD Pharma Group completes acquisition of dsm-firmenich's Marine Lipids business

The transaction positions KD Pharma Group as the largest omega-3 manufacturer in the world

Azelis strengthens its food and nutraceuticals footprint in Poland with the acquisition of Hortimex

The acquisition expands the group’s footprint in Poland, complementing Azelis’ lateral value chain in the food and nutrition segment

Mosaic Flavors bolsters F&B flavour capabilities with acquisition of First Coast Flavors

The companies will work together to serve the unique flavour solutions to the food and beverage industry

Swedencare bolsters premium pet supplement offering with MedVant acquisition

The acquisition will expand the company’s global footprint further into Canada, while also enhancing pet supplement product offering

KD Pharma secures dsm-firmenich's MEG-3 fish oil business in strategic acquisition

KD Pharma will gain all of the MEG-3's assets, including two production facilities and around 200 employees

Green Bioactives receives £224,000 to develop its plant metabolite biomanufacturing platform

The funding from Innovate UK will allow the company to accelerate the development of its botanical metabolite biomanufacturing platform

Tate & Lyle to join forces with CP Kelco

The proposed acquisition bolsters Tate & Lyle's natural ingredients offering, including pectin and speciality gums

GC Rieber VivoMega announces completion of its $75m facility expansion

GC Rieber VivoMega (GCRV) is thrilled to announce the completion and grand opening of its new omega-3 manufacturing facility campus in Norway

dsm-firmenich announces sale of yeast extract business to Lesaffre

dsm-firmenich, innovators in nutrition, health and beauty, has announced an agreement to sell its yeast extract business (Yeast Extracts) to Lesaffre, a key global player in fermentation and micro-organisms

CoreFX Ingredients extends portfolio by acquiring Connoils

The acquisition will enhance CoreFX's current powder delivery systems through Connoils' solutions and expertise

Probi strengthen its position in the Asia-Pacific region through strong customer collaborations

Probi recently launched its first China Innovation Day (CID) to strengthen relations and collaborations with its Chinese customers

Sirio sees surging revenues driven by international sales

Global nutraceutical CDMO reports record $508m turnover

Sponsor content

Dr. Anju Majeed welcomes Maldivian president at the India-Maldives Business Forum

Forum aims to strengthen bilateral ties and explore investment opportunities

Green Origins’ Organic Powders – Powering up from strength to strength

Green Origins has emerged as a leading figure in the global premium organic superfoods ingredient sector, with a strong emphasis on ethically sourced and high-quality...

dsm-firmenich completes the divestiture of its Jiangshan vitamin C plant in China

Financial details of the transaction were not disclosed

Syensqo invests in Bioeutectics, a start-up producing green solvents

The investment, made through Syensqo’s venture capital fund, will contribute to bring more sustainable products and processes to market

dsm-firmenich makes voluntary cash offer for DSM shares

DSM-Firmenich AG and DSM BV (DSM) announce that the remaining holders of DSM ordinary shares will have the opportunity to sell their DSM ordinary shares to dsm-firmenich...

The right ingredients for healthier holiday dessert recipes

Do you love holiday desserts? We already know you do as the proof is in the pudding – along with several other major dessert categories based on global revenue and...

Novozymes and Chr. Hansen announce name of future combined company: Novonesis

Novozymes and Chr. Hansen have announced that the name of the future combined company will be Novonesis

Kerry to acquire Lactase Enzymes Business

The Lactase Enzymes Business had attributable revenue of approximately €40m in 2022 with sales in more than 50 countries

Bühler boosts food innovation with new "Application & Training Centers" in Uzwil

Swiss technology group Bühler unveils its new food innovation hub in Uzwil, Switzerland, bringing together a diverse range of capabilities into a single location and...

Pharmactive Biotech Products joins the B Corp community

Natural extracts leader joins a growing community of companies consciously aligned to meet the highest standards of sustainability and corporate responsibility

Tate & Lyle presents half-year results for the 6 months to 30 September 2023

Tate & Lyle delivered a robust financial performance in the first half of 2023 despite challenging market conditions and made good progress on its growth-focused strategy

Wanda Fish raises $7 million in seed funding to accelerate the pilot production of cultivated bluefin tuna

Netherlands-based aquaculture investment fund, Aqua-Spark, led the round, joined by additional investors The Kitchen Hub, Peregrine Ventures, PICO Venture Partners, MOREVC...